BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Arkus Innovation Studios//The Arkus Signal//EN CALSCALE:GREGORIAN BEGIN:VEVENT UID:nci-imat-r33-2026-application@signal.arkusinnovationstudios.com DTSTAMP:20261103T171233Z DTSTART;VALUE=DATE:20261110 DTEND;VALUE=DATE:20261111 SUMMARY:RFA-CA-27-002: Advanced Development and Validation of Emerging Tech nologies for Basic and Clinical Cancer Research | Submit full application\ , applicant organization local time DESCRIPTION:One good result is the beginning.\nRFA-CA-27-002: Advanced Deve lopment and Validation of Emerging Technologies for Basic and Clinical Can cer Research.\nMaximum $300\,000 a year in direct project costs for up to three years. NCI anticipates approximately $5.9 million shared across an e stimated 13 awards\, subject to appropriations.\nListed higher education i nstitutions\, nonprofits with or without 501(c)(3) status\, businesses\, g overnments and foreign organizations may apply. No clinical trials. Foreig n subawards/subcontracts are prohibited\; direct foreign applicants and ce rtain unfunded collaborations remain permitted under the notice.\nSupporti ve preliminary data must show major feasibility gaps overcome. Active regi strations before submission. No clinical trials or foreign subawards/subco ntracts.\nSubmit full application\, applicant organization local time: 10 November 2026 · 5 p.m. applicant organization local time.\nApplicant-loca l time cannot be converted until the reader chooses the applying organizat ion timezone.\nApplicant-local 5 p.m. cannot be converted without the orga nization’s time zone\; reminder is all-day.\nOfficial information: https ://apply07.grants.gov/grantsws/rest/opportunity/att/download/352669\nAppli cation: https://apply07.grants.gov/grantsws/rest/opportunity/att/download/ 352669\nSources checked 2026-11-03.\nDiscuss working together: nadia@arkus innovationstudios.com\nhttps://www.arkusinnovationstudios.com URL:https://apply07.grants.gov/grantsws/rest/opportunity/att/download/35266 9 END:VEVENT END:VCALENDAR